The reduced expression of lncRNA GAS5 contributed to redox balance and cell cycle progression through increasing expression of Cyclin D1, CDK4, and NOX4, suggesting downregulated GAS5 and increased ROS levels as promising diagnosis or prognosis biomarker for malignant melanoma [50]. This evidence concerns the gene CCND1 and melanoma.